Is Berkshire Hathaway Stock in Trouble?

Operating earnings fell to $10.2B in the most recent quarter, down ~30% YoY from $14.5B (full-year operating earnings declined 6% to $44.5B from $47.4B), with insurance operations cited as the primary drag. Berkshire's stock is down ~2% YTD and flat over six months, trades at ~16x trailing earnings versus the S&P 500 at ~25x, and has a market cap just over $1 trillion. New CEO Greg Abel, who took the helm at the start of the year, emphasizes continuity in investment approach, which tempers governance risk despite near-term earnings weakness.

Analysis

The governance transition reduces single-operator idiosyncrasy and will likely push capital allocation toward process and predictability. That shift tends to favor steady, repeatable uses of cash (systematic buybacks, predictable bolt-on acquisitions) over large, opportunistic concentrated purchases; a change like that can compress near-term alpha but increase the probability of steady EPS accretion and lower realized volatility of book value.

Insurance float remains the wild card for both earnings and marginal deployment into public markets. A deterioration in combined ratios would force a defensive tilt into shorter-duration assets and reduce incremental equity purchases for quarters; conversely, cyclical underwriting recovery would free up float and could produce outsized equity flows within 6–12 months, disproportionately benefiting highly liquid large caps and buyback-heavy issuers.

The market is already pricing a governance haircut versus growth momentum names; that creates asymmetric outcomes depending on two catalysts — visible, recurring buyback cadence or a big M&A deployment. Either catalyst would re-rate the stock higher; absent them, passive and quant flows can continue to underweight the name and pressure relative multiples for several quarters.

For positioning, prefer structure over binary one-way bets: harvest premium and income while keeping optional downside protection across the next 3–12 months, and shift to outright duration (long equity) if you observe a confirmed cadence of capital deployment or a sustained improvement in underwriting trends.

Key Decisions for Investors

• Long BRKB (core position): initiate a 2–4% portfolio weight in BRKB over 1–2 weeks on any 3–6% pullback. Time horizon 12–24 months; target price appreciation +15–25% if buybacks or float redeployment accelerate. Risk-control: hard stop at -12% from entry or halve position on a 10% drawdown.
• Pair trade (value rotation): enter dollar‑neutral long BRKB / short NVDA sized to neutralize beta for a 6–12 month trade. Rationale: capture mean reversion if capital redeployment and underwriting recovery lift BRK while growth momentum cools. Target convergence return 10–15%; tail risk is NVDA re-acceleration — cap loss at -15% of notional on the short leg.